Cargando…
Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
BACKGROUND: The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence based on exp...
Autores principales: | Cook, Robert W., Middlebrook, Brooke, Wilkinson, Jeff, Covington, Kyle R., Oelschlager, Kristen, Monzon, Federico A., Stone, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809902/ https://www.ncbi.nlm.nih.gov/pubmed/29433548 http://dx.doi.org/10.1186/s13000-018-0690-3 |
Ejemplares similares
-
Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study
por: Plasseraud, Kristen Meldi, et al.
Publicado: (2016) -
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients
por: Borman, Sherri, et al.
Publicado: (2022) -
The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma
por: Harbour, J. William, et al.
Publicado: (2013) -
DecisionDx-GBM Gene Expression Assay for Prognostic Testing in Glioblastoma Multiform
por: Allingham-Hawkins, Diane, et al.
Publicado: (2010) -
Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics
por: Plasseraud, Kristen M., et al.
Publicado: (2017)